Targeting Mitochondrial PD-L1 O-GlcNAcylation to Sensitize HBV-Related HCC to Immunotherapy: Modulating Golgi-mitochondrial Crosstalk and mTOR/PGC-1α-Driven Mitochondrial Biogenesis to Overcome Resistance.

Du ZB et al.

NCBI PubMed Central · Papers · License: Open Access

distributed systems architecture

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 653423
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.